Natural history of chronic thromboembolic pulmonary disease with no or mild pulmonary hypertension

医学 肺动脉高压 心脏病学 肺动脉 内科学 血管阻力 肺栓塞 血流动力学
作者
S. Ashwin Reddy,Emilia M. Swietlik,Lucy Robertson,Alice Michael,Sonja Boyle,Gary Polwarth,Nick Screaton,Alessandro Ruggiero,Sarah Nethercott,Dolores Taboada,Karen Sheares,Charaka Hadinnapola,John Cannon,Katherine Bunclark,David P. Jenkins,Choo Ng,Mark Toshner,Joanna Pepke‐Żaba
出处
期刊:Journal of Heart and Lung Transplantation [Elsevier BV]
卷期号:42 (9): 1275-1285 被引量:11
标识
DOI:10.1016/j.healun.2023.04.016
摘要

We describe baseline characteristics, disease progression and mortality in chronic thromboembolic pulmonary disease patients as a function of mean pulmonary artery pressure (mPAP) according to new and previous definitions of pulmonary hypertension.All patients diagnosed with chronic thromboembolic pulmonary disease between January, 2015 and December, 2019 were dichotomized according to initial mPAP: ≤ 20 mmHg ('normal') vs 21-24 mmHg ('mildly-elevated'). Baseline features were compared between the groups, and pairwise analysis performed to determine changes in clinical endpoints at 1-year, excluding those who underwent pulmonary endarterectomy or did not attend follow-up. Mortality was assessed for the whole cohort over the entire study period.One hundred thirteen patients were included; 57 had mPAP ≤ 20 mmHg and 56 had mPAP 21-24 mmHg. Normal mPAP patients had lower pulmonary vascular resistance (1.6 vs 2.5WU, p < 0.01) and right ventricular end-diastolic pressure (5.9 vs 7.8 mmHg, p < 0.01) at presentation. At 3 years, no major deterioration was seen in either group. No patients were treated with pulmonary artery vasodilators. Eight had undergone pulmonary endarterectomy. Over 37 months median follow-up, mortality was 7.0% in the normal mPAP group and 8.9% in the mildly-elevated mPAP group. Cause of death was malignancy in 62.5% of cases.Chronic thromboembolic pulmonary disease patients with mild pulmonary hypertension have statistically higher right ventricular end-diastolic pressure and pulmonary vascular resistance than those with mPAP ≤ 20 mmHg. Baseline characteristics were otherwise similar. Neither group displayed disease progression on non-invasive tests up to 3 years. Mortality over 37 months follow-up is 8%, and mainly attributable to malignancy. Further prospective study is required to validate these findings.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
u305068完成签到,获得积分10
刚刚
小于发布了新的文献求助10
1秒前
2秒前
victor完成签到,获得积分0
2秒前
2秒前
乐乐的应助被谦让的语儿采纳,获得10
3秒前
u989740完成签到,获得积分10
3秒前
3秒前
Sam发布了新的文献求助10
3秒前
康少发布了新的文献求助10
3秒前
4秒前
u149385完成签到,获得积分10
5秒前
Nole的应助被Lily采纳,获得10
5秒前
贾文浩发布了新的文献求助10
5秒前
5秒前
u557314完成签到,获得积分10
5秒前
6秒前
7秒前
Lucas的应助被无私的画笔采纳,获得10
7秒前
8秒前
H11103y发布了新的文献求助10
8秒前
大模型的应助被qin202569采纳,获得10
8秒前
nan发布了新的文献求助10
9秒前
Hik完成签到,获得积分20
9秒前
儒雅的焦发布了新的文献求助10
9秒前
u644628完成签到,获得积分10
10秒前
u936662完成签到,获得积分10
11秒前
11秒前
12秒前
经竺的应助被369ninja采纳,获得10
12秒前
13秒前
ys完成签到,获得积分10
13秒前
赘婿的应助被Wyf采纳,获得10
13秒前
lvyuan完成签到,获得积分10
14秒前
Ava的应助被科研白采纳,获得10
14秒前
15秒前
ad发布了新的文献求助10
15秒前
yy发布了新的文献求助10
15秒前
fb12000发布了新的文献求助10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184508
求助须知:如何正确求助?哪些是违规求助? 9573479
关于积分的说明 21831986
捐赠科研通 7781752
什么是DOI,文献DOI怎么找? 3434372
关于科研通互助平台的介绍 2558482
邀请新用户注册赠送积分活动 2480962